Discover Protalix BioTherapeutics' Q4 2024 earnings insights, including record revenues, pipeline advancements, and future growth prospects.

The Rajasthan Staff Selection Board (RSMSSB) has released the Phase 2 admit cards for the Stenographer and Personal Assistant ...

The Rajasthan Staff Selection Board (RSMSSB) has released Phase 2 admit cards for the Stenographer and Personal Assistant (PA ...

South 21st Street in Tacoma will close from March 26 for 6-8 weeks due to Prairie Line Trail Phase II work, including trail ...

Construction continues on Phase II of the Texas Capitol Complex project, which costs around $500 million. It will house state ...

Biohaven in recent months has reported a clinical stumble in spinal muscular atrophy, alongside a Phase I readout for its ...

Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA) for RN0361-an APOC3 ...

Two Eradivir employees conduct research on the company's EV25 influenza therapeutic. Eradivir, a clinical stage biotech ...

CHINESE and Zanzibar authorities have opened a new chapter of health cooperation, launching the second phase of the ...

Alzamend Neuro (ALZN) announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with PTSD ...